State Pilot Program for Treatment for Pregnant and Postpartum Women

The State Pilot Program for Treatment for Pregnant and Postpartum Women is administered by the U.S. Department of Health and Human Services through the Substance Abuse and Mental Health Services Administration (SAMHSA). SAMHSA is a federal agency tasked with improving behavioral health outcomes across the United States by advancing the prevention and treatment of substance use disorders and mental health conditions. This funding opportunity is part of SAMHSA’s broader initiative to address the growing public health challenges associated with substance use disorders, particularly among vulnerable populations such as pregnant and postpartum women. The primary purpose of this program is to strengthen and expand integrated, evidence-based treatment and recovery services for pregnant and postpartum women experiencing substance use disorders and co-occurring mental health conditions. The program emphasizes improving both maternal and infant health outcomes by supporting comprehensive approaches that include screening, clinical treatment, recovery support services, and workforce development. Special focus is placed on populations disproportionately impacted by maternal morbidity and mortality, including those affected by opioid use disorder and related conditions. Funding under this program is intended to support a wide range of activities that enhance service delivery systems. Allowable uses include implementing evidence-based treatment models, integrating maternal mental health services with substance use disorder care, expanding access to recovery supports, and strengthening workforce capacity to address these needs. The program promotes coordination across healthcare providers, social services, and community-based organizations to ensure a holistic continuum of care for women, their infants, and families. No cost sharing or matching requirement is specified, which lowers financial barriers for eligible applicants. Eligibility for this opportunity is statutorily limited to Single State Agencies (SSAs) responsible for substance use services. These agencies typically oversee statewide systems for prevention, treatment, and recovery services and are positioned to implement large-scale, coordinated interventions. While the eligibility category is listed broadly as “Others,” the clarification restricts applicants specifically to these designated state-level entities, ensuring alignment with federal program requirements and oversight structures. The application process will follow standard federal grant submission procedures through Grants.gov once the opportunity is officially posted. Although detailed application components are not yet provided in this forecast, applicants can expect requirements typical of SAMHSA grants, including program narratives, budget justifications, and documentation demonstrating capacity to implement evidence-based interventions. Evaluation criteria are likely to focus on program design, organizational capacity, alignment with priorities, and expected impact on maternal and infant health outcomes. This opportunity is currently in forecast status, with an estimated posting date of May 29, 2026. Specific deadlines for application submission, award decisions, and project start dates have not yet been announced. The program anticipates making approximately five awards, with total estimated funding of $5,400,000. Interested applicants are encouraged to monitor Grants.gov for updates and prepare in advance. For additional information, SAMHSA has provided a program contact, Tracy Ambos, who can be reached via phone or email for inquiries related to the opportunity.